Short stressor induced long-lasting increases in vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH) neurons in adult rats

Journal of Neuroendocrinology

Volumn 8, Issue 9, 1996, Pages 703-712

  Schmidt, E D ^a   Binnekade, R ^a   Janszen, A W J W ^a   Tilders, F J H ^a,b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Corticotropin releasing hormone (CRH); Hypothalamus; Neuroplasticity; Stress; Vasopressin

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ETHER; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SURGERY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEDIAN EMINENCE; NERVE CELL; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; STRESS; VASOPRESSIN RELEASE;

EID: 0029812377     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.1996.tb00707.x     Document Type: Article

References (74)

1. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7: 351-378.
2. Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982; 299: 355-357.
3. Tilders FJH, Schmidt ED, De Goeij DCE. Phenotypic plasticity of CRF neurons during stress review. Ann N Y Acad Sci 1993; 697: 39-52.
4. Swanson LW. Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res 1991; 87: 181-200.
5. Van Dijken HH, De Goeij DCE, Sutanto W et al. Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats. Neuroendocrinology 1993; 58: 57-64.
6. Schmidt ED, Janszen AWJW, Wouterlood F et al. Interleukin-1 induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal-axis. J Neurosci 1995; 15: 7417-7426.
7. Plotsky PM, Sawchenko PE. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 1987; 120: 1361-1369.
8. De Goeij DCE, Kvetnansky R, Whitnall MH et al. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 1991; 53: 150-159.
9. De Goeij DCE, Binnekade R, Tilders FJH. Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am J Physiol 1992; 263: E394-E399.
10. De Goeij DCE, Dijkstra H, Tilders FJH. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 1992; 131: 847-853.
11. De Goeij DCE, Jezova D, Tilders FJH. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 1992; 577: 165-168.
12. De Goeij DCE, Berkenbosch F, Tilders FJH. Is vasopressin preferentially released from corticotropin-releasing factor and vasopressin containing nerve terminals in the median eminence of adrenalectomized rats? J Neuroendocrinology 1993; 5: 107-113.
13. Bartanusz V, Jezova D, Bertini LT et al. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 1993; 132: 895-902.
14. Bartanusz V, Aubry JM, Jezova D et al. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 1993; 58: 625-629.
15. Bertini LT, Kursner C, Gaillard RC et al. A tissue culture model of the hypophysiotrophic CRF producing neuronal system. Neuroendocrinology 1993; 57: 716-728.
16. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system review. Progr Neurobiol 1993; 40: 573-629.
17. Berkenbosch F, Tilders FJH. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity. Brain Res 1988; 442: 312-320.
18. Tilders FJH, De Goeij DCE, Berkenbosch F. Turnover of corticotropin releasing factor and vasopressin in the median eminence and control of pituitary-adrenal activity. In: Rose FC, ed. The control of the Hypothalamo-Pituitary-Adrenal Axis, Madison, WI: International University Press, 1989: 7-24.
19. Herman JP, Wiegand SJ, Watson SJ. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 1990; 127: 2408-2417.
20. Herman JP, Cullinan WE, Young EA el al. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res 1992; 592: 228-238.
21. Fink G, Robinson IC, Tannahill LA. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood. J Physiol 1988; 401: 329-345.
22. Spinedi E, Giacomini M, Jacquier MC et al. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 1991; 53: 160-170.
23. Makino S, Schulkin J, Smith MA et al. Regulation of corticotropinreleasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 1995; 136: 4517-4525.
24. Luo X, Kiss A, Rabadan-Diehl C et al. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids. Endocrinology 1995; 136: 3877-3883.
25. Luo X, Kiss A, Makara G et al. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 1994; 6: 689-696.
26. Aguilera G. Regulation of pituitary acth secretion during chronic stress review. Front Neuroendocrinol 1994; 15: 321-350.
27. Berkenbosch F, De Goeij DCE, Tilders FJH. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology 1989; 125: 28-34.
28. Guillaume V, Conte-Delvolx B, Magnan E et al. Effect of chronic active immunization with anti-corticotropin releasing factor in the pituitary-adrenal function in the sheep. Endocrinology 1992; 130: 2291-2298.
29. Van Oers JWA, Tilders FJH. Antibodies in passive immunization studies: characteristics and consequences. Endocrinology 1991; 128: 496-503.
30. Ixart G, Barbanel G, Conte-Devolx B et al. Evidence for basal and stress-induced release of corticotropin releasing factor in the pushpull cannulated median eminence of conscious free-moving rats. Neurosci Lett 1987; 74: 85-89.
31. Makara GB, Stark E, Polkovits M. Reevaluation of the pituitary-adrenal response to ether in rats with various cuts around the medial basal hypothalamus. Neuroendocrinology 1980; 30: 38-44.
32. Murakami K, Akana SF, Dallman MF et al. Correlation between the stress-induced transient increase in corticotropin-releasing hormone content of the median eminence of the hypothalamus and adrenocorticotropic hormone secretion. Neuroendocrinology 1989; 49: 233-241.
33. Rivier C. Neuroendocrine mechanisms of anterior pituitary regulation in the rat exposed to stress. In: Brown MR, Koob GF, Rivier C. eds. Stress: Neurobiology and Neuroendocrinology New York, Basel: Marcel Dekker, 1991; 119-135.
34. Schotanus K, Makara GB, Tilders FJH et al. ACTH response to a low dose but not to a high dose of bacterial endotoxin in rats is completely mediated by corticotropin-releasing hormone. Neuroimunomodulation 1994; 1: 300-307.
35. Gaykema RPA, Dijkstra I, Tilders FJH. Vagal efferents mediate endotoxin-induced activation of CRH neurons and ACTH secretion. Endocrinology 1995; 136: 4717-4720.
36. Berkenbosch F, Van Oers JWAM, del Rey A et al. Corticotropinreleasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524-526.
37. Sapolsky RM, Rivier C, Yamamoto G et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522-524.
38. Ericsson A, Kovacs KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 1994; 14: 897-913.
39. Rivest S, Rivier C. Stress and interleukin-1β induced activation of c-fos, NGF-B and CRF gene expression in the hypothalamic PVN: comparison between Sprague-Dawley, Fisher-344 and Lewis rats. J Neuroendocrinol 1994; 6: 101-117.
40. Rivier C, Vale WW. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 1987; 305: 325-327.
41. Pezzone MA, Lee WS, Hoffman GE, Rabin BS. Induction of c-Fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res 1992; 597: 41-50.
42. Barbanel G, Ixart G, Szafarczyk A. Intrahypothalamic infusion of interleukin-1 beta increases the release of corticotropin-releasing hormone (CRH 41) and adrenocorticotropic hormone (ACTH) in free-moving rats bearing a push-pull cannula in the median eminence. Brain Res 1990; 516: 31-36.
43. Rivest S, Torres G, Rivier C. Differential effects of central and peripheral injection of interleukin-1 beta on brain c-fos expression and neuroendocrine functions. Brain Res 1992; 587: 13-23.
44. Ceccatelli S, Orazzo C. Effect of different types of Stressors on peptide messenger ribonucleic acids in the hypothalamic paraventricular nucleus. Acta Endocrinol 1993; 128: 485-492.
45. Gaillet S, Laucher J, Assenmacher I et al. A The involvement of ascending noradrenergic pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of the Stressors. Exp Brain Res 1991; 87: 173-180.
46. Kjaer A, Knigge U, Langer Madsen E et al. Insulin/hypoglycemia-induced adrenocorticotropin and beta-endorphin release: Involvement of hypothalamic histaminergic neurons. Endocrinology 1993; 132: 2213-2220.
47. Barbanel G, Gaillet S, Mekaouche M et al. Complex catecholaminergic modulation of the stimulatory effect of interleukin-1 beta in the corticotropic axis. Brain Res 1993; 626: 31-36.
48. Ohgo S, Nakatsuru K, Ishikawa E. Interleukin-1 (IL-1) stimulates the release of corticotropin-releasing factor (CRF) from superfused rat hypothalamo-neuronypophyseal complexes (HNC) independently of the histaminergic mechanism. Brain Res 1991; 558: 217-223.
49. Van Oers JWAM, Jezova D, Kvetnansky R et al. CRH-dependent and CRH-independent components in stress-induced ACTH secretion. In: McCarty R, Aguilera G, Sabban E, Kvetnansky R, eds. Stress: Molecular Genetic and Neurobiological Advances, New York: Gordon and Breach Science Publishers, 1996.
50. Spinedi E, Negro-Villar A. Insulin hypoglycemia. Neuroendocrinology 1983; 37: 446-453.
51. Robinson B, Mealy K, Wilmore DW. The effect of insulin-induced hypoglycemia on gene expression in the hypothalamic-pituitary-adrenal axis of the rat. Endocrinology 1992; 130: 920-925.
52. Strbak V, Guillaume V, Grino M. Passive immunization and hypothalamic peptide secretion. Neuroendocrinology 1993; 58: 210-217.
53. Whitnall MH, Perlstein RS, Mougey EH. Effects of interleukin-1 on the stress-responsive and nonresponsive subtypes of corticotropinreleasing hormone neurosecretory axons. Endocrinology 1992; 131: 37-44.
54. Berkenbosch F, De Goeij DCE, Rey AD et al. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 1989; 50: 570-576.
55. Plotsky PM, Bruhn TO, Vale WW. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 1985; 117: 323-329.
56. Maren S, Baudry M. Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory, [review]. Neurobiol Learning Mem 1995; 63: 1-18.
57. Gozlan H, Khazipov R, Ben-Ari Y. Multiple forms of long-term potentiation and multiple regulatory sites of n-methyl-d-aspartate receptors: role of the redox site review. J Neurobiol 1995; 26: 360-369.
58. Richter-Levin G, Canevari L, Bliss TV. Long-term potentiation and glutamate release in the dentate gyrus: links to spatial learning review. Beh Brain Res 1995; 66: 37-40.
59. Nicoll RA, Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus review. Nature 1995; 377: 115-118.
60. Bourtchuladze R, Frenguelli B, Blendy J et al. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994; 79: 59-68.
61. Nguyen PV, Abel T, Kandel ER. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994; 265: 1104-1107.
62. Nedivi E, Hevroni D, Naot D et al. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 1993; 363: 718-722.
63. McDonald TJ, Hoffman GE, Nathanielsz PW. Hypothalamic paraventricular nuclear lesions delay corticotroph maturation in the fetal sheep anterior pituitary. Endocrinology 1992; 131: 1101-1106.
64. Herman JP, Cullinan WE, Watson SJ. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol 1994; 6: 433-442.
65. Demmer J, Dragunow M, Lawlor PA. Differential expression of immediate early genes after hippocampal long-term potentiation in awake rats. Brain Res Molecular Brain Res 1994; 17: 279-286.
66. Makino S, Smith MA, Gold PW. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mrna) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mrna levels. Endocrinology 1995; 136: 3299-3309.
67. Schotanus K, Tilders FJH, Berkenbosch F. Human recombinant interleukin-1 receptor antagonist prevents ACTH but not interleukin-6 responses to low doses of bacterial endotoxin rats. Endocrinology 1993; 133: 2461-2468.
68. Persoons JH, Berkenbosch F, Schornagel K et al. Increased specific IgE production in lungs after the induction of acute stress in rats. J Allergy Clin Immunol 1995; 95: 765-770.
69. Van Oers JWA, Hinson JP, Binnekade R et al. Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland. Endocrinology 1992; 130: 282-288.
70. Kovacs KJ, Makara GB. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy induced adrenocorticotropin hypersecretion. Brain Res 1988; 474: 205-210.
71. DeMan AJM, Benraad TJ. Aldosterone secretion rate: radioimmunoassay versus double isotope dilution derivative assay. Clin Chim Acta 1977; 79: 489-501.
72. Koenig JI, Klippel RA. In: The rat brain. A stereotactic atlas of the forebrain and lower parts of the brainstem. Baltimore, USA: William & Wilkins 1963; 1.
73. Van der Sluis PJ, Pool CW, Sluiter AA. Immunochemical detection of peptides and proteins on press-blots after direct tissue gel isoelectric focusing. Electrophoresis 1988; 9: 654-661.
74. Berkenbosch F, Linton EA, Tilders FJH. Colocalization of peptide histidine isoleucine amine and corticotropin-releasing factor immunoreactivity in neurons of the rat hypothalamus: a surprising artefact. Neuroendocrinology 1986; 44: 338-346.